Schonfeld Strategic Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Buy |
33,615
+4,145
| +14% | +$22K | ﹤0.01% | 1708 |
|
|
2025
Q1 | $261K | Sell |
29,470
-3,450
| -10% | -$30.6K | ﹤0.01% | 1721 |
|
|
2024
Q4 | $451K | Buy |
32,920
+14,475
| +78% | +$198K | ﹤0.01% | 1388 |
|
|
2024
Q3 | $505K | Sell |
18,445
-14,424
| -44% | -$395K | ﹤0.01% | 1290 |
|
|
2024
Q2 | $804K | Buy |
+32,869
| New | +$804K | 0.01% | 1171 |
|
|
2019
Q3 | – | Sell |
-59,400
| Closed | -$1.65M | – | 1149 |
|
|
2019
Q2 | $1.65M | Sell |
59,400
-44,054
| -43% | -$1.22M | 0.06% | 331 |
|
|
2019
Q1 | $3.44M | Buy |
103,454
+83,354
| +415% | +$2.77M | 0.12% | 229 |
|
|
2018
Q4 | $584K | Buy |
+20,100
| New | +$584K | 0.02% | 619 |
|